On the upside
Citi Investment Research analyst Jim Suva upgraded Brightpoint (Nasdaq: CELL) and increased his price target for the company saying that cell phone sales should improve.
WuXi PharmaTech (NYSE: WX) reported sharply higher second quarter earnings as margins improved and expenses fell.
The Food and Drug Administration approved CryoLife's (NYSE: CRY) human heart patch.
On the downside
Stifel Nicolaus analyst David Ross downgraded YRC Worldwide (Nasdaq: YRCW) saying that despite recent union concessions, the transportation services company is still likely to file for bankruptcy.
Vanguard Natural Resources (NYSE: VNR) priced its offering of 3.5 million common shares at $14.25 per share.
Gushan Environmental Energy (NYSE: GU) swung to a second quarter loss as revenue tumbled.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on the NYSE and by nearly 5 to 2 on Nasdaq. The Russell 2000 which tracks small cap stocks climbed 10 points to 572.
